Enanta Pharmaceuticals, Inc. (ENTA)
13.51
-0.49
(-3.50%)
USD |
NASDAQ |
Feb 20, 16:00
13.65
+0.14
(+1.04%)
After-Hours: 20:00
Enanta Pharmaceuticals SG&A Expense (Quarterly) : 9.009M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Agios Pharmaceuticals, Inc. | 51.61M |
| ACADIA Pharmaceuticals, Inc. | 133.40M |
| Alnylam Pharmaceuticals, Inc. | 325.37M |
| Savara, Inc. | 9.627M |
| BioMarin Pharmaceutical, Inc. | 268.40M |